PSPH and breast carcinoma: Cancer cells with LKB1 loss increase the expression of phosphoserine aminotransferase 1 (PSAT1), phosphoserine phosphatase (PSPH) and serine hydroxylmethyltransferase (SHMT1/2) involving de novo serine synthesis pathway (SSP) in breast cancer [10].